会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明授权
    • Activation of fibrillation and tachycardia functions
    • 激活原纤维性颤动和心动过速功能
    • US07110813B2
    • 2006-09-19
    • US10413001
    • 2003-04-15
    • Paul J. DegrootKevin T. Ousdigian
    • Paul J. DegrootKevin T. Ousdigian
    • A61N1/38
    • A61N1/3956A61N1/3622
    • An implantable medical device may be programmed by a programmer to apply a variety of ventricular fibrillation (VF) and ventricular tachycardia (VT) therapies, such as antitachycardia pacing (ATP) and cardioversion shocks. In general, the invention is directed to automatic activation of VF- and VT-related functions upon a single command. When a clinician interacts with the programmer to set VF therapies to active status, for example, VT therapies are automatically set to active status as well. Activation of several VF- and VT-related functions with a single command may save considerable time and may be beneficial to the patient. The invention further provides the freedom to customize the functions to the particular needs of a single patient or a group of patients.
    • 植入式医疗装置可以由程序员编程以应用各种心室颤动(VF)和室性心动过速(VT)疗法,例如抗心动过速起搏(ATP)和心律转复休克。 通常,本发明涉及在单个命令上自动激活VF和VT相关功能。 当临床医生与程序员进行交互以将VF治疗设置为活动状态时,例如,VT治疗也会自动设置为活动状态。 通过单个命令激活几个VF和VT相关功能可以节省大量的时间并且可能对患者有益。 本发明还提供了根据单个患者或一组患者的特定需要来定制功能的自由度。
    • 10. 发明申请
    • HEART FAILURE MONITORING
    • 心力衰竭监测
    • US20120253207A1
    • 2012-10-04
    • US13436408
    • 2012-03-30
    • Shantanu SarkarJodi L. RedemskeEduardo N. WarmanDouglas A. HettrickKevin T. Ousdigian
    • Shantanu SarkarJodi L. RedemskeEduardo N. WarmanDouglas A. HettrickKevin T. Ousdigian
    • A61B5/0205
    • A61B5/0006A61B5/0004A61B5/7275G06F19/3418G16H40/40G16H50/30
    • Techniques for transmitting diagnostic information stored in an implantable medical device (IMD) based on patient hospitalization are described. For example, the IMD may transmit higher resolution diagnostic information to a clinician and/or an external device during a hospitalization period to aid the clinician in evaluating heart failure treatment and when discharge is proper. This higher resolution diagnostic information may include one or more patient metrics automatically generated and transmitted by the IMD at least once every two hours. During a post-hospitalization period, the IMD may transmit lower resolution diagnostic information to a clinician that indicates a risk level of re-hospitalization. The lower resolution diagnostic information may include the risk level and/or patient metrics once a day, for example. In this manner, the IMD transmitted diagnostic information may be tailored to the specific heart failure monitoring needed by the patient.
    • 描述了基于患者住院时间传送存储在可植入医疗装置(IMD)中的诊断信息的技术。 例如,IMD可以在住院期间向临床医师和/或外部设备传送更高分辨率的诊断信息,以帮助临床医师评价心力衰竭治疗以及放电是否合适。 该更高分辨率的诊断信息可以包括由IMD自动生成和发送的至少每两小时一次的一个或多个患者度量。 在住院后期间,IMD可以向临床医生传递较低分辨率的诊断信息,指示重新住院的风险水平。 例如,较低分辨率诊断信息可以包括一天一次的风险水平和/或患者度量。 以这种方式,IMD传输的诊断信息可以针对患者所需的特定心力衰竭监测。